[Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
In a total of 532 patients, Bilivistan and Endomirabil are compared in cholecystography regarding side effects and visualization. Endomirabil clearly demonstrates the advantage of better tolerance. It is shown that slow and constant injection leads to a decrease in the rate of adverse reactions and improvement of radiographic demonstration.
D000328:Adult; D000368:Aged; D002765:Cholecystography / Q000009:adverse effects / Q000379:methods*; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007463:Iodobenzoates; D007471:Ioglycamic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D007471:Ioglycamic Acid
Injektions-Cholegraphie. Der Einfluss von Kontrastsubstanz und Injektionszeit auf Konstrast-mittelausscheidung und Nebenwirkungen